ACE2 Receptor and Antibody Binding to SARS-CoV‑2 Spikes and Virions by Single-Molecule Fluorescence

ACE2 Receptor and Antibody Binding to SARS-CoV‑2 Spikes and Virions by Single-Molecule Fluorescence

Saved in:

Bibliographic Details
Main Authors:	Souradip Dasgupta, Srijan Ray, Aswin T. Srivatsav, Anthony L. DeVico, Krishanu Ray
Format:	Article
Language:	English
Published:	American Chemical Society 2025-07-01
Series:	ACS Omega
Online Access:	https://doi.org/10.1021/acsomega.5c03887
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Critical amino acid residues in human ACE2 for SARS-CoV-2 spike protein binding and virus entry
by: Weiyi Chen, et al.
Published: (2025-08-01)

Evolutionary Analysis of Mammalian ACE2 and the Key Residues Involved in Binding to the Spike Protein Revealed Potential SARS-CoV-2 Hosts
by: Luciano Rodrigo Lopes1, et al.
Published: (2022-03-01)

Computational Design and Evaluation of Peptides to Target SARS-CoV-2 Spike–ACE2 Interaction
by: Saja Almabhouh, et al.
Published: (2025-04-01)

The SARS-CoV-2 Spike protein has a broad tropism for mammalian ACE2 proteins.
by: Carina Conceicao, et al.
Published: (2020-12-01)

Characterization of key spike RBD residues influencing SARS-CoV-2 variant adaptation to avian ACE2
by: Weitong Yao, et al.
Published: (2025-07-01)

Engineering functionally-optimized aptamers against SARS-Cov-2 for blocking spike-ACE2 interaction and aptasensor detection
by: Xiangdong Lai, et al.
Published: (2025-08-01)

In Vitro Inhibitory Effect of Nigella sativa L. Extracts on SARS-COV-2 Spike Protein-ACE2 Interaction
by: Najma Ali, et al.
Published: (2024-01-01)

Missense variants in human ACE2 strongly affect binding to SARS-CoV-2 Spike providing a mechanism for ACE2 mediated genetic risk in Covid-19: A case study in affinity predictions of interface variants.
by: Stuart A MacGowan, et al.
Published: (2022-03-01)

Receptor binding and structural basis of raccoon dog ACE2 binding to SARS-CoV-2 prototype and its variants.
by: Chunliang Luo, et al.
Published: (2024-12-01)

Peptides derived from the SARS-CoV-2 receptor binding motif bind to ACE2 but do not block ACE2-mediated host cell entry or pro-inflammatory cytokine induction.
by: Amit Mahindra, et al.
Published: (2021-01-01)

Disrupting SARS-CoV-2 Spike–ACE2 Interactions via Glycosaminoglycans in a Pseudoviral Study of Heparan Sulfate and Enoxaparin
by: Virginia Fuochi, et al.
Published: (2025-06-01)

Venom Peptides of Crotalus atrox Against SARS-Cov-2 Spike Protein and Human ACE2 Receptor by Molecular Docking Analysis
by: Süleyman İlhan
Published: (2023-08-01)

Impedimetric Sensor for SARS-CoV-2 Spike Protein Detection: Performance Assessment with an ACE2 Peptide-Mimic/Graphite Interface
by: Diego Quezada, et al.
Published: (2024-12-01)

Pharmacophore mapping of Angiotensin Converting Enzymes (ACEs): Insight to Binding Site of ACE1 and ACE2
by: Navista Sri Octa Ujiantari, et al.
Published: (2024-10-01)

Aptamer Paper-Based Fluorescent Sensor for Determination of SARS-CoV-2 Spike Protein
by: Jincai Yang, et al.
Published: (2025-03-01)

Combined immunization with SARS-CoV-2 spike and SARS-CoV nucleocapsid protects K18-hACE2 mice but increases lung pathology
by: Jaekwan Kim, et al.
Published: (2025-02-01)

SARS‐CoV‐2 spike protein enhances MAP4K3/GLK‐induced ACE2 stability in COVID‐19
by: Huai‐Chia Chuang, et al.
Published: (2022-07-01)

Why HIV virions have low numbers of envelope spikes: implications for vaccine development.
by: John Schiller, et al.
Published: (2014-08-01)

In vitro evolution predicts emerging SARS-CoV-2 mutations with high affinity for ACE2 and cross-species binding.
by: Neil Bate, et al.
Published: (2022-07-01)

Immunogenic Potential of Selected Peptides from SARS-CoV-2 Proteins and Their Ability to Block S1/ACE-2 Binding
by: Lara Cristina da Silva Lima, et al.
Published: (2025-01-01)

Characterization of Nanobody Binding to Distinct Regions of the SARS-CoV-2 Spike Protein by Flow Virometry
by: Mariam Maltseva, et al.
Published: (2025-04-01)

Molecular Determinants for the Binding of the Highly Infectious SARS-CoV-2 Omicron (BA.1) Variant to the Human ACE2 Receptor
by: Majed S. Aljohani, et al.
Published: (2025-02-01)

Interfacial subregions of SARS-CoV-2 spike RBD to hACE2 affect intermolecular affinity by their distinct roles played in association and dissociation kinetics
by: Xiangwu Tang, et al.
Published: (2024-12-01)

Detection of breastmilk antibodies targeting SARS-CoV-2 nucleocapsid, spike and receptor-binding-domain antigens
by: D. M. Favara, et al.
Published: (2020-01-01)

Potential Beneficial Role of Nitric Oxide in SARS-CoV-2 Infection: Beyond Spike-Binding Inhibition
by: Sergio Sánchez-García, et al.
Published: (2024-10-01)

Hypoxia reduces cell attachment of SARS-CoV-2 spike protein by modulating the expression of ACE2, neuropilin-1, syndecan-1 and cellular heparan sulfate
by: Endika Prieto-Fernández, et al.
Published: (2021-01-01)

Neutralisation resistance of SARS-CoV-2 spike-variants is primarily mediated by synergistic receptor binding domain substitutions
by: Long V. Pham, et al.
Published: (2024-12-01)

Kaurenoic acid is a potent inhibitor of SARS-CoV-2 RNA synthesis, virion assembly, and release in vitro
by: Igor Andrade Santos, et al.
Published: (2025-05-01)

Natural compounds from ethno-medicinal plants exhibit multiple binding activities on SARS-CoV-2 spike protein receptor-binding domains
by: Trizah K. Milugo, et al.
Published: (2025-05-01)

Relationship of ACE1 and ACE2 genetic polymorphisms on SARS-CoV-2 infection and severity of symptoms in different regions of Iraq
by: Bilal Ali Khashan, et al.
Published: (2024-02-01)

Role of ACE1, ACE2, and CCR5-Δ32 Polymorphisms in the Transmission of SARS-CoV-2 to Intimate Contacts
by: Maria Pina Dore, et al.
Published: (2025-05-01)

SARS-CoV-2 spike S2-specific neutralizing antibodies
by: Chia-Jung Li, et al.
Published: (2023-12-01)

Evaluation and Its Impact of SARS-CoV-2 Inactivated Vaccine Candidate in K18-hACE2 Mice
by: Rofiqul A'la, et al.
Published: (2025-04-01)

Correction: Development of ACE2 autoantibodies after SARS-CoV-2 infection.
by: John M Arthur, et al.
Published: (2024-01-01)

Fixation and reversion of mutations in the receptor-binding domain of the SARS-CoV-2 spike protein: A 2020–2024 analysis
by: Daniele Focosi, et al.
Published: (2024-12-01)

Spike substitutions E484D, P812R and Q954H mediate ACE2-independent entry of SARS-CoV-2 across different cell lines.
by: Greta Vizgirda, et al.
Published: (2025-01-01)

Peptide-Based Inhibitors of Protein–Protein Interactions (PPIs): A Case Study on the Interaction Between SARS-CoV-2 Spike Protein and Human Angiotensin-Converting Enzyme 2 (hACE2)
by: Aizhan Rakhmetullina, et al.
Published: (2024-10-01)

Human soluble ACE2 improves the effect of remdesivir in SARS‐CoV‐2 infection
by: Vanessa Monteil, et al.
Published: (2020-12-01)

ACE2 Receptor Usage across Animal Species by SARS-CoV-2 Variants
by: Masato Hatta, et al.
Published: (2025-08-01)

Daphnetin may protect from SARS-CoV-2 infection by reducing ACE2
by: Qian-wen Yang, et al.
Published: (2024-12-01)